Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders
Franz Felix Konen, Nora Möhn, Torsten Witte, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103312-103312
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
Dongze Wu, Yingzhao Jin, Yuhan Xing, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102193-102193
Open Access | Times Cited: 47
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders
Franz Felix Konen, Nora Möhn, Torsten Witte, et al.
Autoimmunity Reviews (2025) Vol. 24, Iss. 4, pp. 103754-103754
Closed Access
LILRB4 as a novel immunotherapeutic target for multiple diseases
Xu Wang, Lanying Li, Dan Liu, et al.
Biochemical Pharmacology (2025), pp. 116762-116762
Closed Access
Ferroptosis: A New Pathway in the Interaction between Gut Microbiota and Multiple Sclerosis
Junjie Jian, Jun Wei
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
Impact of Whole-Body Cryotherapy on Pain, Sleep Quality, Functional Status, and Quality of Life in Multiple Sclerosis: A Comparative Study with Follow-Up
Ewa Zielińska-Nowak, Anna Lipert, Łukasz Kikowski, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 46-46
Open Access
Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials
Liuting Zeng, Chang Liu, Yang Wu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Unveiling Ocular Manifestations in Systemic Lupus Erythematosus
Mutali Musa, Ekele Chukwuyem, Oluwasola Michael Ojo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1047-1047
Open Access | Times Cited: 4
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Piero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 7-8, pp. 103581-103581
Closed Access | Times Cited: 4
Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis
Tristan Kölsche, Alice Willison, Marc Horbrügger, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 8, pp. 1086-1088
Closed Access | Times Cited: 3
Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis
Jing-Ying Wu, Jiang-Li Yang, Jialing Hu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
In vitro identification of single-stranded DNA aptamers targeting human IL-23 using the protein-SELEX strategy
Mohammad Ali Rezaee, Saeideh Sadat Shobeiri, Malihe Moghadam, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 247, pp. 116245-116245
Closed Access | Times Cited: 2
Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis
Dnyandev Gadhave, Vrashabh V. Sugandhi, Chandrakant Kokare
Brain Research (2023) Vol. 1822, pp. 148674-148674
Closed Access | Times Cited: 6
Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas
Steffen Pfeuffer
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 7, pp. 897-898
Open Access | Times Cited: 1
SARS-CoV-2 Infection and Multiple Sclerosis: Proactive Approach in a Vulnerable Patient Group through Daily Vitamin D Supplementation?
Hans Goischke, K. Hans
(2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Identifying Diagnostic Markers and Constructing Predictive Models for Oxidative Stress in Multiple Sclerosis
Yantuanjin Ma, Fang Wang, Qiting Zhao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7551-7551
Open Access | Times Cited: 1
The pentraxin family in autoimmune disease
Yongzhen Li, Shouzan Zhang, Jingqi Liu, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117592-117592
Closed Access | Times Cited: 3
A perplexing case report of concomitant multiple sclerosis and myasthenia gravis
Mustafa Al-Mollah, Moaiad Hussein, Jamil Qiqieh, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 7, pp. 4236-4240
Open Access
A Review on Autoimmune Diseases: Recent Advances and Future Perspectives
Balid Albarbar
AlQalam Journal of Medical and Applied Sciences (2024), pp. 718-729
Open Access
Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study
Clara Aguirre, Ana Alonso, Eduardo Agüera, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 11, pp. 829-838
Closed Access
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients
Konstantin Fritz Jendretzky, Lisa-Marie Lezius, Thea Thiele, et al.
Neurological Research and Practice (2024) Vol. 6, Iss. 1
Open Access
Understanding Multiple Sclerosis Pathophysiology and Current Disease-Modifying Therapies: A Review of Unaddressed Aspects
Eiman M. A. Mohammed
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 11
Open Access
Case report: Tofacitinib alleviates psoriatic arthritis without exacerbating multiple sclerosis
Yaran Yang, Wei Zhou
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 3
Closed Access
Comorbilidades en la esclerosis múltiple y su influencia en la elección del tratamiento
Andrés Barboza, Vladimiro Sinay, Ricardo Alonso, et al.
Revista de Neurología (2024) Vol. 78, Iss. 06, pp. 157-157
Open Access
A case of multiple autoimmune syndrome comprising autoimmune thyroid disease, vitiligo, morphea, and lichen sclerosus
Hana Gašper, Vesna Breznik
Acta Dermatovenerologica Alpina Pannonica et Adriatica (2024) Vol. 33, Iss. 2
Open Access
Effect of Mediterranean diet on body mass index and fatigue severity in patients with multiple sclerosis: a systematic review and meta-analysis of clinical trials
Amir Reza Moravejolahkami, Mehdi Shakibaei, Manoj Sharma, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37705-e37705
Open Access
Page 1 - Next Page

Scroll to top